Robert S.D. Higgins, MD, MSHA, serves as president of Brigham and Women’s Hospital and executive vice president at Mass General Brigham. Higgins is responsible for the vitality and success of the clinical, academic and educational mission of the Brigham in support of patients locally and across the globe. His leadership role within the Mass General Brigham system involves setting and guiding strategy, priorities, and performance.
Brigham and Women's Hospital earned an 'A' Safety Grade from The Leapfrog Group for the fall of 2021. This distinction recognizes our dedication to protecting patients from harm and offering the safest health care. The Leapfrog Group assigns grades A-F to all general hospitals in the nation based on their patient care performance in avoiding medical errors, injuries, accidents, infections and other harms.
The trial will test the safety and efficacy of a new vaccine intended to prevent and slow the progression of Alzheimer’s disease (AD). The trial represents the culmination of nearly 20 years of research led by Howard L. Weiner, MD, co-director of the Ann Romney Center for Neurologic Diseases.
Your contribution will aid our efforts on every front as we work together to defeat COVID-19, care for our patients and families in their hours of greatest need, and emerge stronger than ever.Give Now
We are inspired by our patients’ courage, our caregivers’ compassion, and our scientists’ curiosity—all fueled by our donors’ generosity.
Imagine what we can do together.